Exaggerated blood pressure response to standing in young-to-middle-age subjects: prevalence and factors involved.


Journal

Clinical autonomic research : official journal of the Clinical Autonomic Research Society
ISSN: 1619-1560
Titre abrégé: Clin Auton Res
Pays: Germany
ID NLM: 9106549

Informations de publication

Date de publication:
08 2023
Historique:
received: 03 03 2023
accepted: 04 04 2023
medline: 21 8 2023
pubmed: 29 4 2023
entrez: 29 4 2023
Statut: ppublish

Résumé

To investigate the prevalence of orthostatic hypertension and the association of the blood pressure (BP) level, supine BP decline, and white-coat effect with the orthostatic pressor response. We studied 1275 young-to-middle-age individuals with stage-1 hypertension. Orthostatic response was assessed three times over a 3 month period. The white-coat effect was assessed at baseline and after 3 months, and was calculated as the difference between office and average 24 h BP. In 660 participants, urinary epinephrine and norepinephrine were also measured. An orthostatic systolic BP increase ≥ 20 mmHg was observed in 0.6-1.2% of the subjects during the three visits. Using the 20 mmHg cut-off, the prevalence of orthostatic hypertension was 0.6%. An orthostatic BP increase of ≥ 5 mmHg was found in 14.4% of participants. At baseline, the orthostatic response to standing showed an independent negative association with the supine BP level (p < 0.001), the supine BP change from the first to third measurement (p < 0.001), and the white-coat effect (p < 0.001). Similar results were obtained in the 1080 participants assessed at the third visit. Urinary epinephrine showed higher values in the top BP response decile (systolic BP increase ≥ 6 mmHg, p = 0.002 versus rest of the group). An orthostatic systolic BP reaction ≥ 20 mmHg is rare in young adults. However, even lower BP increases may be clinically relevant. The BP level, the supine BP decline over repeated measurement, and the white-coat effect can influence the estimate of the BP response to standing and should be considered in clinical and pathogenetic studies.

Identifiants

pubmed: 37119425
doi: 10.1007/s10286-023-00942-0
pii: 10.1007/s10286-023-00942-0
pmc: PMC10439022
doi:

Substances chimiques

Epinephrine YKH834O4BH

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

391-399

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2023. The Author(s).

Références

J Hypertens. 2016 Jun;34(6):1068-74
pubmed: 27032073
J Hypertens. 2007 Jul;25(7):1327-36
pubmed: 17563549
Circulation. 1994 Dec;90(6):2870-6
pubmed: 7994832
Acta Physiol Scand. 1975 May;94(1):139-41
pubmed: 1155162
Int J Epidemiol. 2005 Feb;34(1):215-20
pubmed: 15333621
Hypertens Res. 2004 Apr;27(4):235-41
pubmed: 15127880
J Hypertens. 2022 Oct 1;40(10):1927-1934
pubmed: 36052521
Hypertension. 2016 Oct;68(4):888-95
pubmed: 27504006
J Hypertens. 2006 Aug;24(8):1479-87
pubmed: 16877948
Stroke. 1997 Nov;28(11):2169-73
pubmed: 9368559
Int J Endocrinol. 2015;2015:463487
pubmed: 26078756
Clin Auton Res. 2023 Feb;33(1):69-73
pubmed: 36173501
J Clin Hypertens (Greenwich). 2019 Mar;21(3):426-433
pubmed: 30724451
J Geriatr Cardiol. 2016 Mar;13(3):239-43
pubmed: 27103919
Clin Auton Res. 2023 Feb;33(1):29-40
pubmed: 36473959
J Hum Hypertens. 2019 Oct;33(10):735-740
pubmed: 30804464
Hypertension. 1985 Mar-Apr;7(2):196-203
pubmed: 3980066
J Am Coll Cardiol. 2002 Jul 3;40(1):133-41
pubmed: 12103267
J Am Soc Hypertens. 2016 Nov;10(11):847-856
pubmed: 27665708
Hypertension. 1999 Jan;33(1):36-43
pubmed: 9931079
Hypertension. 2016 Jan;67(1):191-6
pubmed: 26597824
Mayo Clin Proc. 2003 Aug;78(8):951-8
pubmed: 12911043
Am J Hypertens. 2015 Oct;28(10):1248-56
pubmed: 25767137
J Diabetes Complications. 2009 Mar-Apr;23(2):83-8
pubmed: 18413171
Am J Hypertens. 2010 Aug;23(8):829-37
pubmed: 20414196
Br J Pharmacol. 1981 Jul;73(3):669-79
pubmed: 6113865
Hypertens Res. 2005 Jan;28(1):15-9
pubmed: 15969250
Hypertension. 2022 May;79(5):984-992
pubmed: 35296159
J Hypertens. 2000 Jun;18(6):769-75
pubmed: 10872563
Hypertens Res. 2008 May;31(5):897-904
pubmed: 18712045
Hypertension. 2020 May;75(5):1151-1158
pubmed: 32223382
Am J Med. 1997 Sep;103(3):208-16
pubmed: 9316553
J Clin Hypertens (Greenwich). 2017 Dec;19(12):1357-1365
pubmed: 28929576
Hypertension. 1998 Jan;31(1):77-82
pubmed: 9449395
J Hypertens. 2021 Jul 1;39(7):1293-1302
pubmed: 33710173
Front Physiol. 2014 Mar 04;5:86
pubmed: 24624092
Hypertension. 2000 Feb;35(2):614-20
pubmed: 10679506
Kidney Int. 2006 Aug;70(3):578-84
pubmed: 16788693
Diagnostics (Basel). 2023 Jan 25;13(3):
pubmed: 36766538
Blood Press Monit. 2017 Aug;22(4):184-190
pubmed: 28263203
Hypertension. 1994 Feb;23(2):211-6
pubmed: 8307631
Hypertens Res. 2008 Aug;31(8):1509-16
pubmed: 18971524
J Clin Hypertens (Greenwich). 2019 Jul;21(7):877-883
pubmed: 31215143
Cardiovasc Diabetol. 2016 Jun 02;15:83
pubmed: 27255168

Auteurs

Paolo Palatini (P)

Studium Patavinum and Department of Medicine, University of Padova, Via Giustiniani 2, 35128, Padua, Italy. palatini@unipd.it.

Lucio Mos (L)

San Antonio Hospital, San Daniele del Friuli, Italy.

Marcello Rattazzi (M)

Studium Patavinum and Department of Medicine, University of Padova, Via Giustiniani 2, 35128, Padua, Italy.

Andrea Ermolao (A)

Studium Patavinum and Department of Medicine, University of Padova, Via Giustiniani 2, 35128, Padua, Italy.

Francesca Battista (F)

Studium Patavinum and Department of Medicine, University of Padova, Via Giustiniani 2, 35128, Padua, Italy.

Olga Vriz (O)

San Antonio Hospital, San Daniele del Friuli, Italy.

Mattia Canevari (M)

San Antonio Hospital, San Daniele del Friuli, Italy.

Francesca Saladini (F)

Cittadella Town Hospital, Cittadella, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH